NGNE

Conviction 98HealthcareScan · Mon, Aug 10, 2026

NGNE$36.45+2.12%

ResistanceSupportVol 14Insider sell

Vol MA14 166.21K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Neurogene Inc.PHARMACEUTICAL PREPARATIONSwww.neurogene.com ↗

Price36.45

Change+2.12%

Gap+0.04%

Rel volume2.40×

Avg volume188.85K

Avg $ vol6.79M

SMA 2035.60

SMA 5033.12

SMA 20025.35

Price vs 50+10.03%

Price vs 200+43.78%

MA stackbullish

50/200 cross—

Supertrendup · 31.74

RSI (14)57

MACD hist-0.06

MACD cross—

Stoch %K / %D93 / 74

ADX (14)16

+DI / −DI17 / 18

RSI divergence—

MACD divergence—

ATR %+5.85%

ADR %5.73%

52w high42.84

52w low16.37

From 52w high-14.93%

Above 52w low+122.63%

New 52w highNo

SqueezeOff

Bollinger width20.58%

%B0.62

Donchian pos56.51%

Donchian high40.00

Donchian low31.83

AVWAP (52w high)36.71

vs AVWAP high-0.72%

AVWAP (52w low)28.36

vs AVWAP low+28.51%

OBV trendFlat

Chaikin MF (20)0.22

Today vs 20d2.40×

Avg vol (14d)166.21K

Avg vol (20d)188.85K

Avg $ vol (20d)6.79M

Market cap575.9M

RS 3m (vs SPY)+8.47%

RS 6m (vs SPY)+103.91%

RS line new highNo

Trend template8/8

Technical rank79.1

1 week+10.88%

1 month-8.04%

3 months+18.40%

6 months+111.52%

1 year+69.83%

YTD+80.78%

P/E-6.37

P/B2.42

P/S—

P/FCF-7.35

EPS-4.24

Div yield—

ROE-38.00%

ROA-34.34%

Debt/Eq—

Current13.08

EV/EBITDA-4.50

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-20.24%

Price target80.71

Target upside121.46%

Analyst ratingBuy

Institutional91.32%

Ent. value451.74M

Revenue0

Net income-30.93M

Gross profit—

Free cash flow-78.36M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out15.8M

Employees131

ListedTue, Dec 19, 2023

Free float9.74M

Float %62.9%

Short interest2.93M

Days to cover7.6d

Short volume56.3%

Squeeze score91 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.39 vs −$1.35

Last surprise-3.0% miss

Setup gradeA+

Conviction98 / 100

Pattern quality—

Tech rank79.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance41.83

Support30.00

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Retesting breakout
Jun 9
1 scan
→
Setting up
Jun 26
1 scan

Congress activity

Disclosed STOCK Act trades in NGNE

All disclosures →

No recent disclosed trades by Congress in NGNE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NGNE · 1 buy · 3 sells

Insider	Side	Shares	Value	Traded	Filed
Cvijic Christine Mikail President and CFO · Common Stock · 2026-07-07	Sell	4.2K	$152K	2026-07-07	2026-07-07
Cvijic Christine Mikail President and CFO · Common Stock · 2026-07-06	Sell	600	$22K	2026-07-06	2026-07-07
Cvijic Christine Mikail President and CFO · Common Stock · 2026-05-06	Sell	4.8K	$156K	2026-05-06	2026-05-08
Shafer Christina Chief Commercial Officer · Non-Qualified Stock Option (right to buy) · 2026-05-05	Grant	120K	$0	2026-05-05	2026-05-07

SEC filings

EDGAR filings in NGNE · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.